Coronary flow reserve in young men with familial combined hyperlipidemia

Circulation

Volumn 99, Issue 13, 1999, Pages 1678-1684

  Pitkänen, Olli Pekka ^a   Nuutila, Pirjo ^a   Raitakari, Olli T ^b   Porkka, Kimmo ^d   Iida, Hidehiro ^f   Nuotio, Ilpo ^a   Rönnemaa, Tapani ^a   Viikari, Jorma ^a   Taskinen, Marja Riitta ^e   Ehnholm, Christian ^d   Knuuti, Juhani ^c,g  

^a Turku University   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU PET CENTRE   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Blood flow; Hyperlipidemia, familial combined; Lipids; Myocardium; Tomography

Indexed keywords

DIPYRIDAMOLE;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART RATE VARIABILITY; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; MALE; PATHOPHYSIOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0344609244     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.13.1678     Document Type: Article

References (46)

1. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis. 1987;7:203-207.
2. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. Hyperlipidaemia in coronary heart disease, I: lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973;52:1533-1543.
3. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidaemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidaemia. J Clin Invest. 1973;52:1544-1568.
4. Hazzard WR, Goldstein JL, Schrott HG, Motulsky AG, Bierman EL. Evaluation of lipoprotein phenotypes in 156 genetically defined survivors of myocardial infarction. J Clin Invest. 1973;52:1569-1577.
5. Lusis J. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res. 1988;29:397-429.
6. Rauh G, Schuster H, Müller B, Schewe S, Keller C, Wolfram G, Zöllner N. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 1990;83: 81-87.
7. Coresh J, Beaty TH, Kwiterovich PO, Antonarakis SE. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am J Hum Genet. 1992;50:1038-1045.
8. Nevin DN, Brunzell JD, Deeb SS. The LpL gene in individuals with familial combined hyperlipidemia and decreased LpL activity. Arterioscler Thromb. 1994;14:869-873.
9. Gagne E, Genest JR, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LpL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb. 1994;14:1250-1257.
10. Pajukanta P, Porkka KV, Antikainen M, Taskinen MR, Perola M, Murtomäki-Repo S, Ehnholm S, Nuotio I, Suurinkeroinen L, Lahdenkari AT, Syvänen AC, Viikari JS, Ehnholm C, Peltonen L. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families. Arterioscler Thromb Vasc Biol. 1997;17:841-850.
11. Nikkilä EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet. 1973;1:954-959.
12. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, Pihlajamäki J, Suomalainen AJ, Syvänen AC, Lehtimäki T, Viikari JS, Laakso M, Taskinen MR, Ehnholm C, Peltonen L. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet. 1998;18: 369-373.
13. Vakkilainen J, Porkka KVK, Nuotio I, Pajukanta P, Suurinkeroinen L, Ylitalo K, Viikari JSA, Ehnholm C, Taskinen M-R. Glucose intolerance in familial combined hyperlipidaemia. Eur J Clin Invest. 1998;28:24-32.
14. Porkka KVK, Nuotio I, Pajukanta P, Ehnholm C, Suurinkeroinen L, Syvänne M, Lehtimäki T, Lahdenkari A-T, Lahdenperä S, Ylitalo K, Antikainen M, Perola M, Raitakari OT, Kovanen P, Viikari JSA, Peltonen L, Taskinen M-R. Phenotype expression in familial combined hyperlipidemia. Atherosclerosis. 1997;133:245-253.
15. 15O. Circulation. 1984;70:724-733.
16. Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, Schelbert HR. Nitrogen-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989; 80:1328-1337.
17. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
18. Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, Galassi A, De Silva R, Jones T, Maseri A. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 1991;83:875-885.
19. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schweiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-817.
20. Pitkänen O-P, Raitakari OT, Niinikoski H, Nuutila P, Iida H, Voipio-Pulkki L-M, Härkönen R, Wegelius U, Rönnemaa T, Viikari JSA, Knuuti J. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol. 1996;28:1705-1711.
21. Pitkänen O-P, Nuutila P, Raitakari OT, Rönnemaa T, Koskinen PJ, Iida H, Lehtimäki TJ, Laine HK, Takala T, Viikari JSA, Knuuti J. Coronary flow reserve is reduced in young men with insulin-dependent diabetes mellitus. Diabetes. 1998;47:248-254.
22. Pitkänen O-P, Raitakari OT, Rönnemaa T, Niinikoski H, Nuutila P, Iida H, Viikari JSA, Knuuti J. Influence of cardiovascular risk status on coronary flow reserve in healthy young men. Am J Cardiol. 1997;79: 1690-1692.
23. Raitakari OT, Pitkänen O-P, Lehtimäki T, Lahdenperä S, Iida H, Ylä-Herttuala S, Luoma J, Mattila K, Nikkari T, Taskinen M-L, Viikari JSA, Knuuti J. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am Coll Cardiol. 1997;30:97-102.
24. Clark J, Crouzel C, Meyer G, Strijckmans K. Current methodology for oxygen-15 production for clinical use. Int J Rad Appl Instrum. 1987;38: 597-600.
25. Crouzel C, Clark J, Brihaye C, Långström O, Lemaire C, Meyer G, Nebeling B, Stone-Elander S. Radiochemistry automation for PET. In: Stöcklin G, Pike V, eds. Radiopharmaceuticals for Positron Emission Tomography. Norwell, Mass: Kluwer Academic Publishers; 1993:45-90.
26. 15O and dynamic positron-emission tomography: strategy for quantification in relation to the partial-volume effect. Circulation. 1988;78:104-115.
27. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma A. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med. 1995;36:78-85.
28. Iida H, Rhodes C, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med. 1992;33:1669-1677.
29. Syvänne M, Vuorinen-Markkola H, Hilden H, Taskinen M-R. Gemfibrozil reduces postprandial lipidemia in non-insulin-dependent diabetes mellitus. Arterioscler Thromb. 1993;13:286-295.
30. Taskinen M-R, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H. Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis. 1988;8:168-177.
31. Cuthbert JA, East CA, Bilheimer DW, Lipsky PE. Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. N Engl J Med. 1986;314:879-883.
32. Keys A, ed. Coronary heart disease in seven countries: American Heart Association Monograph 29. Circulation. 1970;41(suppl I):I-1-I-211.
33. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2-14.
34. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease. Circulation. 1998;97:1029-1036.
35. Miller M, Vogel RA. Nontraditional risk factors. In: Miller M, Vogel RA, eds. The Practice of Coronarv Disease Prevention. Baltimore, Md: Williams & Wilkins; 1996:175-207.
36. Castro Cabezas M, de Bruin TW, Erkelens DW. Familial combined hyperlipidemia: 1973-1991. Neth J Med. 1992;40:83-95.
37. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 1996;94:3232-3238.
38. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 1994;330:1782-1788.
39. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
40. Camici PG, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, Parodi O, Salvadori PA, Nista N, Papi L. Coronary vasodilatation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 1991; 17:879-886.
41. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
42. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol. 1993;22:650-658.
43. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250: H1145-H1149.
44. Leipert B, Becker BF, Gerlach E. Different endothelial mechanisms involved in coronary responses to known vasodilators. Am J Physiol. 1992;262:H1676-H16783.
45. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res. 1992;29:353-358.
46. Lupi A, Buffon A, Finocchiaro ML, Conti E, Maseri A, Crea F. Mechanisms of adenosine-induced epicardial coronary artery dilatation. Eur Heart J. 1997;18:614-617.